Keros Therapeutics (KROS) Stock Chart & Stock Price History $15.04 +0.16 (+1.08%) Closing price 04:00 PM EasternExtended Trading$15.04 0.00 (0.00%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Keros Therapeutics Stock Price Performance The Keros Therapeutics (KROS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 74.75%, with a year-to-date return of -4.99%. In the past month, the stock has decreased 4.51%, reflecting recent market activity. As of the latest close, Keros Therapeutics traded at $14.88 with a market cap of $453.39 million and volume of 819,331 shares. Five years ago, the stock traded at $53.91, representing a 72.10% decrease over that period. At the time, it had a market cap of $1.09 billion and a volume of 42,149 shares. Receive KROS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+8.75%1 Month Performance-4.51%3 Month Performance+4.59%Year-To-Date Performance-4.99%1 Year Performance-74.75%5 Year Performance-72.10% KROS Stock Chart for Friday, October, 24, 2025 KROS Chart by TradingView Keros Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/23/2025$15.56$14.88-4.37%$15.65$14.85819,331 shs$453.39 million10/22/2025$15.41$15.56+0.97%$15.76$15.03815,228 shs$631.97 million10/21/2025$15.19$15.41+1.45%$15.49$14.92977,300 shs$625.95 million10/20/2025$13.83$15.19+9.83%$15.46$13.962.23 million shs$617.02 million10/17/2025$13.74$13.83+0.66%$13.91$13.60660,531 shs$561.78 million10/16/2025$14.49$13.74-5.18%$14.83$13.652.16 million shs$558.05 million10/15/2025$15.09$14.49-3.98%$15.03$13.935.81 million shs$588.58 million10/14/2025$15.89$15.09-5.03%$15.89$15.06517,016 shs$612.96 million10/13/2025$15.70$15.89+1.21%$16.14$15.65496,743 shs$645.37 million10/10/2025$16.12$15.70-2.61%$16.18$15.68448,219 shs$637.66 million Get the Latest News and Ratings for KROS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/09/2025$15.96$16.12+1.00%$16.44$15.90508,948 shs$654.79 million10/08/2025$15.65$15.96+1.98%$16.43$15.67533,616 shs$648.30 million10/07/2025$15.62$15.65+0.19%$15.89$15.50307,923 shs$635.63 million10/06/2025$15.94$15.62-2.01%$16.57$15.59410,474 shs$634.48 million10/03/2025$15.58$15.94+2.31%$16.37$15.61476,037 shs$647.48 million10/02/2025$15.28$15.58+1.96%$15.66$15.00813,715 shs$632.86 million10/01/2025$15.82$15.28-3.41%$15.96$15.08914,375 shs$620.60 million09/30/2025$15.95$15.82-0.82%$16.08$15.75536,509 shs$642.61 million09/29/2025$16.05$15.95-0.62%$16.30$15.67271,285 shs$647.89 million09/26/2025$15.80$16.05+1.58%$16.11$15.71393,408 shs$651.95 million09/25/2025$15.75$15.80+0.32%$15.88$15.55220,256 shs$641.72 million09/24/2025$15.69$15.75+0.38%$15.86$15.56183,484 shs$639.77 million09/23/2025$15.90$15.69-1.32%$15.99$15.65204,786 shs$637.33 million Related Companies Avadel Pharmaceuticals Stock Price Chart Vera Therapeutics Stock Price Chart Arcus Biosciences Stock Price Chart Sionna Therapeutics Stock Price Chart Stoke Therapeutics Stock Price Chart Biohaven Stock Price Chart AbCellera Biologics Stock Price Chart Harmony Biosciences Stock Price Chart Cogent Biosciences Stock Price Chart Phibro Animal Health Stock Price Chart Receive KROS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KROS) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredWhat Wall Street Won’t Say Out LoudDiscover the 7 key indicators before everyone else doesAmerican Alternative | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.For the everyday American who's worked hard to build their nest egg, Trump preserved a IRS loophole that allow...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Keros Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Keros Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
